US Patent 8933115 Stabilized statin formulations
Patent 8933115 was granted and assigned to Cumberland Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+141 characters)
Article
Patent abstract
The present invention is directed to statin formulations having improved solubility and/or stability and methods for the same.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08933115 Stabilized statin formulations US Patent 8933115 Stabilized statin formulations
Infobox
Patent Number
0893311500
Patent Number
893311500
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089331150
Date of Patent
January 13, 2015
0Patent Application Number
137469990
Date Filed
January 22, 2013
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089331150
Date of Patent
January 13, 2015
0Patent Application Number
137469990
Date Filed
January 22, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08933115 Stabilized statin formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08933115
Date of patent
January 13, 2015
Patent application number
13746999
Date Filed
January 22, 2013
Patent primary examiner
Find more entities like US Patent 8933115 Stabilized statin formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.